Caxton Associates LLP Fulgent Genetics, Inc. Transaction History
Caxton Associates LLP
- $2.87 Trillion
- Q1 2025
A detailed history of Caxton Associates LLP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 62,863 shares of FLGT stock, worth $1.26 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
62,863Holding current value
$1.26 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding FLGT
# of Institutions
197Shares Held
17.7MCall Options Held
379KPut Options Held
52.9K-
Black Rock Inc. New York, NY3.92MShares$78.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.97MShares$39.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$23.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.03MShares$20.6 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN625KShares$12.5 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $607M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...